User contributions
Jump to navigation
Jump to search
- 19:00, 27 June 2021 diff hist +6 m Editing test page 2 Tag: visualeditor
- 00:12, 3 June 2021 diff hist +706 Billing codes (CPT) and wRVUs →Outpatient: updated with 2021 time criteria Tag: visualeditor
- 06:29, 10 May 2021 diff hist -96 Tutorial →Ontology Tag: visualeditor
- 16:56, 24 April 2021 diff hist +84 User:Linhnguyen Tag: visualeditor
- 16:54, 24 April 2021 diff hist +8 m File:Linh nguyen.jpg →Summary current
- 16:54, 24 April 2021 diff hist +42 N User:Linhnguyen Created page with "thumb|Linh Nguyen"
- 16:53, 24 April 2021 diff hist +34 N File:Linh nguyen.jpg Linh Nguyen headshot
- 23:29, 8 April 2021 diff hist +1 m Prostate cancer →BAT {{#subobject:aoc10a |Regimen=1}}
- 22:44, 20 March 2021 diff hist +13 m Palbociclib (Ibrance) →Diseases for which it is used
- 14:36, 6 March 2021 diff hist +132 N User:Ddymshyts Created page with "Dmitry Dymshyts MD is [https://www.ohdsi.org/who-we-are/collaborators/dmitry-dymshyts/ technical lead of the OHDSI vocabulary team]." current
- 07:21, 1 February 2021 diff hist -1 m Editing test page 2 test edit Tag: visualeditor
- 06:20, 22 January 2021 diff hist +1 m Editing test page 2 Tag: visualeditor
- 20:36, 14 January 2021 diff hist +28 m Venetoclax (Venclexta) →Acute myeloid leukemia: updated FDA indication
- 17:31, 3 January 2021 diff hist -20 m Editing test page 2 Tag: visualeditor
- 18:41, 31 December 2020 diff hist +146 User:Donnarivera current Tag: visualeditor
- 12:34, 23 December 2020 diff hist +14 m Editing test page 2 Tag: visualeditor
- 12:33, 8 December 2020 diff hist +451 N User:Tganta Created page with "thumb|Teja Ganta, MD Teja Ganta, MD is a hematology/oncology fellow at Icahn School of Medicine at Mount Sinai and The Mount Sinai Hospital focusing on..."
- 12:33, 8 December 2020 diff hist +43 N File:Tejaganta.jpg Teja Ganta, MD headshot photo current
- 15:38, 5 December 2020 diff hist +58 User:PeterYang →Personal useful information
- 22:18, 26 November 2020 diff hist -3 m Editing test page 2 test edit Tag: visualeditor
- 00:49, 26 November 2020 diff hist 0 m Neuroblastoma →Naxitamab {{#subobject:f725b0|Regimen=1}}: regimen/variant tag
- 00:48, 26 November 2020 diff hist +1,492 Neuroblastoma →Relapsed or refractory: added Naxitamab
- 00:40, 26 November 2020 diff hist 0 File:Sargramostim.pdf PeterYang uploaded a new version of File:Sargramostim.pdf current
- 00:18, 26 November 2020 diff hist +61 m Drug index →N
- 00:17, 26 November 2020 diff hist -2 m Naxitamab (Danyelza) →Diseases for which it is used
- 00:16, 26 November 2020 diff hist +3,016 N Naxitamab (Danyelza) FDA approval
- 23:50, 25 November 2020 diff hist 0 File:Apalutamide.pdf PeterYang uploaded a new version of File:Apalutamide.pdf
- 23:48, 25 November 2020 diff hist +5 m File:Naxitamab-gqgk.pdf current
- 23:48, 25 November 2020 diff hist +37 N File:Naxitamab.pdf PeterYang moved page File:Naxitamab.pdf to File:Naxitamab-gqgk.pdf current Tag: New redirect
- 23:48, 25 November 2020 diff hist 0 m File:Naxitamab-gqgk.pdf PeterYang moved page File:Naxitamab.pdf to File:Naxitamab-gqgk.pdf
- 23:47, 25 November 2020 diff hist +149 N File:Naxitamab-gqgk.pdf Naxitamab (Danyelza) package insert (locally hosted backup). Original source: https://labeling.ymabs.com/danyelza, accessed 11/25/2020.
- 20:45, 19 November 2020 diff hist +25 m Small cell lung cancer →Lurbinectedin monotherapy {{#subobject:35730b|Regimen=1}}: added NCT
- 20:42, 19 November 2020 diff hist +1,649 Small cell lung cancer added Lurbinectedin
- 20:28, 19 November 2020 diff hist 0 File:Trabectedin.pdf PeterYang uploaded a new version of File:Trabectedin.pdf current
- 20:28, 19 November 2020 diff hist +187 Trabectedin (Yondelis) updated links
- 20:26, 19 November 2020 diff hist -2 m Lurbinectedin (Zepzelca)
- 20:21, 19 November 2020 diff hist +2,843 N Lurbinectedin (Zepzelca) FDA approval
- 20:07, 19 November 2020 diff hist +87 m Drug index →L: added Lurbinectedin (Zepzelca) Tag: visualeditor
- 20:06, 19 November 2020 diff hist +167 N File:Lurbinectedin.pdf Lurbinectedin (Zepzelca) package insert (locally hosted backup). Original source: https://pp.jazzpharma.com/pi/zepzelca.en.USPI.pdf, accessed 11/19/2020. current
- 20:04, 19 November 2020 diff hist 0 File:Enzalutamide.pdf PeterYang uploaded a new version of File:Enzalutamide.pdf
- 14:22, 4 November 2020 diff hist +364 Performance status added ECOG-ACRIN link Tag: visualeditor
- 13:35, 4 November 2020 diff hist +433 Performance status →Comparing Karnofsky performance scale & ECOG performance status: updated KPS and ECOG comparison Tag: visualeditor
- 21:04, 26 October 2020 diff hist -178 m Editing test page Undo revision 46515 by PeterYang (talk) Tag: Undo
- 21:02, 26 October 2020 diff hist +178 m Editing test page test edits Tag: visualeditor
- 07:20, 24 October 2020 diff hist +887 Testicular cancer statistics and patient information links Tag: visualeditor
- 06:37, 19 October 2020 diff hist -9 m Editing test page 2 test edit Tag: visualeditor
- 16:39, 15 October 2020 diff hist +465 Pembrolizumab (Keytruda) →Classical Hodgkin lymphoma (cHL): FDA approval Tag: visualeditor
- 16:24, 15 October 2020 diff hist 0 File:Nivolumab.pdf PeterYang uploaded a new version of File:Nivolumab.pdf
- 16:22, 15 October 2020 diff hist 0 File:Ipilimumab.pdf PeterYang uploaded a new version of File:Ipilimumab.pdf
- 16:06, 15 October 2020 diff hist 0 File:Pembrolizumab.pdf PeterYang uploaded a new version of File:Pembrolizumab.pdf